ILUMINOS THERAPEUTICS LLC
Illuminating new treatments for Alzheimer's disease
ORO VALLEY, United States · Founded 2022 · $2.9M raised
- Headquarters
- ORO VALLEY, Arizona
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2G
- Total Funding
- $2.9M
- Last Round
- $2.9M GrantJan 2022
- Rounds
- 1
About
Iluminos Therapeutics is a preclinical-stage biotechnology company developing small molecule inhibitors of DYRK1A kinase to treat Alzheimer's disease and related neurodegenerative conditions. The company was founded based on technology licensed from the University of Arizona and has received approximately $3.5M in NIH/SBIR federal grants to advance its lead candidate DYR533 toward clinical trials. Its initial focus is on Alzheimer's disease in patients with Down syndrome.
Summary
ILUMINOS THERAPEUTICS LLC is a Biotech company based in ORO VALLEY, United States, founded in 2022. It has raised $2.9M in total across 1 round, most recently a $2.9M Grant round in Jan 2022. Investors include Department of Health and Human Services.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2022
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.